tetano
Editor, Senior Moderator
Natl Sci Rev
. 2022 Sep 20;9(11):nwac192.
doi: 10.1093/nsr/nwac192. eCollection 2022 Nov.
Long-term outcomes in COVID-19 patients who recovered from the first wave of the pandemic
Dan Cui[SUP] 1 2 [/SUP], Simiao Chen[SUP] 3 4 [/SUP], Luzhao Feng[SUP] 4 [/SUP], Mengmeng Jia[SUP] 4 [/SUP], Yeming Wang[SUP] 2 [/SUP], Weijun Xiao[SUP] 4 [/SUP], Yanxia Sun[SUP] 4 [/SUP], Qiangru Huang[SUP] 4 [/SUP], Libing Ma[SUP] 4 5 [/SUP], Zhiwei Leng[SUP] 4 [/SUP], Hao Wang[SUP] 4 [/SUP], Bin Cao[SUP] 2 6 [/SUP], Weizhong Yang[SUP] 4 [/SUP], Juntao Yang[SUP] 7 [/SUP], Chen Wang[SUP] 1 2 4 6 [/SUP]
Affiliations
Abstract
This cross-sectional study evaluated the long-term health effects of coronavirus disease 2019 (COVID-19) in Jianghan District (Wuhan, China). The results showed that 61.4% of COVID-19 patients reported at least one symptom and 8.8% had depressive symptoms at the 17-month follow-up. The proportion of patients with chest radiographic abnormalities in Fangcang shelter hospitals and designated COVID-19 hospitals was 31.6% and 41.1%, respectively, and the proportion of patients with impaired pulmonary diffusion capacity in these hospitals was 52.8% and 60.9%, respectively. Female sex (odds ratio [OR] = 1.48, 95% confidence interval [CI]: 1.16-1.88), severe disease (OR = 1.46, 95% CI: 1.01-2.10) and a higher number of initial symptoms (OR = 1.31, 95% CI: 1.23-1.40) were associated with the development of sequelae symptoms at 17 months. This study involving community-dwelling COVID-19 adults may help determine the long-term effects of COVID-19 during the first pandemic wave. Nonetheless, larger follow-up studies are needed to characterize the post-COVID-19 condition.
Keywords: SARS-CoV-2; follow-up studies; post-COVID-19 syndrome.
. 2022 Sep 20;9(11):nwac192.
doi: 10.1093/nsr/nwac192. eCollection 2022 Nov.
Long-term outcomes in COVID-19 patients who recovered from the first wave of the pandemic
Dan Cui[SUP] 1 2 [/SUP], Simiao Chen[SUP] 3 4 [/SUP], Luzhao Feng[SUP] 4 [/SUP], Mengmeng Jia[SUP] 4 [/SUP], Yeming Wang[SUP] 2 [/SUP], Weijun Xiao[SUP] 4 [/SUP], Yanxia Sun[SUP] 4 [/SUP], Qiangru Huang[SUP] 4 [/SUP], Libing Ma[SUP] 4 5 [/SUP], Zhiwei Leng[SUP] 4 [/SUP], Hao Wang[SUP] 4 [/SUP], Bin Cao[SUP] 2 6 [/SUP], Weizhong Yang[SUP] 4 [/SUP], Juntao Yang[SUP] 7 [/SUP], Chen Wang[SUP] 1 2 4 6 [/SUP]
Affiliations
- PMID: 36478734
- PMCID: PMC9718796
- DOI: 10.1093/nsr/nwac192
Abstract
This cross-sectional study evaluated the long-term health effects of coronavirus disease 2019 (COVID-19) in Jianghan District (Wuhan, China). The results showed that 61.4% of COVID-19 patients reported at least one symptom and 8.8% had depressive symptoms at the 17-month follow-up. The proportion of patients with chest radiographic abnormalities in Fangcang shelter hospitals and designated COVID-19 hospitals was 31.6% and 41.1%, respectively, and the proportion of patients with impaired pulmonary diffusion capacity in these hospitals was 52.8% and 60.9%, respectively. Female sex (odds ratio [OR] = 1.48, 95% confidence interval [CI]: 1.16-1.88), severe disease (OR = 1.46, 95% CI: 1.01-2.10) and a higher number of initial symptoms (OR = 1.31, 95% CI: 1.23-1.40) were associated with the development of sequelae symptoms at 17 months. This study involving community-dwelling COVID-19 adults may help determine the long-term effects of COVID-19 during the first pandemic wave. Nonetheless, larger follow-up studies are needed to characterize the post-COVID-19 condition.
Keywords: SARS-CoV-2; follow-up studies; post-COVID-19 syndrome.